BridgeMD
New treatment option for Type 1 Diabetes
Official title DASH-Obesity: Explainable AI for Family-Centric Personalized Weight Control in Adolescents and Young Adults With Obesity and Chronic Conditions
ClinicalTrials.gov ID: NCT07638345
What this study is testing
- What it's testing
- This prospective single-arm feasibility study evaluates the Adhera Caring Digital Program for Obesity (ACDP-O), a family-centered digital health intervention designed to support adolescents and young adults with overweight/obesity and chronic conditions, including type 1 diabetes (T1D) and asthma. The intervention combines personalized educational content, wearable-device monitoring, psychometric assessments, and explainable artificial intelligence (AI) to improve mental well-being, quality of life, and adherence to healthy lifestyle behaviors.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Adult caregiver (aged 18 years or older) of an adolescent or young adult aged 12 to 21 years diagnosed with Type 1 Diabetes (T1D) or asthma.
- The caregiver is actively involved in the management of the adolescent's or young adult's condition.
- The adolescent or young adult must meet one of the following criteria:
- T1D and normal weight (BMI between the 10th and 85th percentile), or
- T1D and overweight/obesity (BMI ≥85th percentile), or
You likely can't join if
- Severe psychiatric or cognitive conditions that would interfere with participation in the digital intervention.
- Current participation in another obesity- or chronic disease-related digital health intervention study.
- Inability or unwillingness to comply with study procedures.
- Refusal or inability to provide informed consent.
See the full eligibility criteria
- Adult caregiver (aged 18 years or older) of an adolescent or young adult aged 12 to 21 years diagnosed with Type 1 Diabetes (T1D) or asthma.
- The caregiver is actively involved in the management of the adolescent's or young adult's condition.
- The adolescent or young adult must meet one of the following criteria:
- T1D and normal weight (BMI between the 10th and 85th percentile), or
- T1D and overweight/obesity (BMI ≥85th percentile), or
- Asthma and overweight/obesity (BMI ≥85th percentile).
- Willingness to participate in the Adhera Caring Digital Program-Obesity (ACDP-O).
- Access to a smartphone or internet-enabled device compatible with the study application.
- Willingness to provide self-reported information regarding the adolescent's or young adult's health status, including disease-related and anthropometric measures.
- For caregivers of participants with T1D, willingness to share continuous glucose monitoring (CGM) information.
- Severe psychiatric or cognitive conditions that would interfere with participation in the digital intervention.
- Current participation in another obesity- or chronic disease-related digital health intervention study.
- Inability or unwillingness to comply with study procedures.
- Refusal or inability to provide informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Seville, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seville, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.